TLR4-MyD88-TRAF6-TAK1 Complex-Mediated NF-κB Activation Contribute to the Anti-Inflammatory Effect of V8 in LPS-Induced Human Cervical Cancer SiHa Cells
- 692 Downloads
The synthetic compound 7-4-[Bis-(2-hydroxyethyl)-amino]-butoxy-5-hydroxy-8-methoxy-2-phenylchromen-4-one (V8) is a novel flavonoid-derived compound. In this study, we investigated the effects of V8 on Toll-like receptor 4 (TLR4)-mediated inflammatory reaction in human cervical cancer SiHa cells and lipopolysaccharide (LPS)-induced TLR4 activity in cervical cancer SiHa (HPV16+) cells, but not in HeLa (HPV18+) and C33A (HPV−) cells. In addition, V8 inhibited LPS-induced expression of TLR4, MyD88, TRAF6 and phosphorylation of TAK1, and their interaction with TLR4 in SiHa cells, resulting in an inhibition of TLR4-MyD88-TRAF6-TAK1 complex. Moreover, V8 blocked LPS-induced phosphorylation of IκB and IKK, resulting in inhibition of the nuclear translocation of P65-NF-κB in SiHa cells. We also found that V8 reduced the expression of NF-κB target genes, such as those for COX-2, iNOS, IL-6, IL-8, CCL-2, and TNF-α in LPS-stimulated SiHa cells. These results suggested that V8 exerted an anti-inflammatory effect on SiHa cells by inhibiting the TLR4-MyD88-TRAF6-TAK1 complex-mediated NF-κB activation.
KEY WORDSV8 cervical cancer TLR4 NF-κB inflammation HPV16
Conflict of Interest
The authors have no conflicting financial interests.
- 9.Hasan, U.A., E. Bates, F. Takeshita, A. Biliato, R. Accardi, V. Bouvard, M. Mansour, I. Vincent, L. Gissmann, T. Iftner, M. Sideri, F. Stubenrauch, and M. Tommasino. 2007. TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16. Journal of Immunology 178: 3186–3197.CrossRefGoogle Scholar
- 13.Bao, C., H. Namgung, J. Lee, H.C. Park, J. Ko, H. Moon, H.W. Ko, and H.J. Lee. 2014. Daidzein suppresses tumor necrosis factor-alpha induced migration and invasion by inhibiting hedgehog/Gli1 signaling in human breast cancer cells. Journal of Agricultural and Food Chemistry 62: 3759–3767.CrossRefPubMedGoogle Scholar
- 14.Moskot M, Jakobkiewicz-Banecka J, Smolinska E, Piotrowska E, Wegrzyn G, Gabig-Ciminska M. (2015). Effects of flavonoids on expression of genes involved in cell cycle regulation and DNA replication in human fibroblasts. Molecular and Cellular Biochemistry.Google Scholar
- 16.Rafacho, B.P., C.P. Stice, C. Liu, A.S. Greenberg, L.M. Ausman, and X.D. Wang. 2015. Inhibition of diethylnitrosamine-initiated alcohol-promoted hepatic inflammation and precancerous lesions by flavonoid luteolin is associated with increased sirtuin 1 activity in mice. Hepatobiliary Surgery and Nutrition 4: 124–134.PubMedCentralPubMedGoogle Scholar
- 18.Patel K, Singh GK, Patel DK. 2014. A review on pharmacological and analytical aspects of naringenin. Chinese Journal of Integrative Medicine.Google Scholar
- 19.Srinivasan A, Thangavel C, Liu Y, Shoyele S, Den RB, Selvakumar P, Lakshmikuttyamma A. (2015). Quercetin regulates beta-catenin signaling and reduces the migration of triple negative breast cancer. Molecular Carcinogenesis.Google Scholar
- 20.Ge W, Yin Q, Xian H. 2015. Wogonin induced mitochondrial dysfunction and endoplasmic reticulum stress in human malignant neuroblastoma cells via IRE1alpha-dependent pathway. Journal of Molecular Neuroscience: MN. Google Scholar
- 24.Kim, M.S., Y. Bak, Y.S. Park, D.H. Lee, J.H. Kim, J.W. Kang, H.H. Song, S.R. Oh, and Y. Yoon do. 2013. Wogonin induces apoptosis by suppressing E6 and E7 expressions and activating intrinsic signaling pathways in HPV-16 cervical cancer cells. Cell Biology and Toxicology 29: 259–272.CrossRefPubMedGoogle Scholar
- 25.Yang, L., H.W. Zhang, R. Hu, Y. Yang, Q. Qi, N. Lu, W. Liu, Y.Y. Chu, Q.D. You, and Q.L. Guo. 2009. Wogonin induces G1 phase arrest through inhibiting Cdk4 and cyclin D1 concomitant with an elevation in p21Cip1 in human cervical carcinoma HeLa cells. Biochemistry and Cell Biology = Biochimie et Biologie Cellulaire 87: 933–942.CrossRefPubMedGoogle Scholar